FDA Inspection 1042622 - Braintree, A part of SEBELA Pharmaceuticals - February 28, 2018

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Record Details

This FDA Inspection record concerns Braintree, A part of SEBELA Pharmaceuticals, with an inspection on February 28, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: Braintree, A part of SEBELA Pharmaceuticals
Inspection Date: February 28, 2018
Product Type: Drugs
Office: Center for Drug Evaluation and Research

Open in Dashboard

ID · 717fe323-8916-49e3-b346-16040875b8a5

Violation Codes2

21 CFR 211.198(b)(1)21 CFR 211.84(c)(4)

Full citation text and observation details available on the Dashboard.